1. Home
  2. HOUR vs NSRX Comparison

HOUR vs NSRX Comparison

Compare HOUR & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hour Loop Inc.

HOUR

Hour Loop Inc.

N/A

Current Price

$1.90

Market Cap

66.8M

ML Signal

N/A

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$4.62

Market Cap

53.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HOUR
NSRX
Founded
2015
2019
Country
United States
Israel
Employees
151
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.8M
53.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
HOUR
NSRX
Price
$1.90
$4.62
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$20.50
AVG Volume (30 Days)
10.9K
2.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
128.57
N/A
EPS
0.07
N/A
Revenue
$138,252,861.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$27.14
N/A
Revenue Growth
4.64
N/A
52 Week Low
$1.10
$3.99
52 Week High
$6.84
$9.99

Technical Indicators

Market Signals
Indicator
HOUR
NSRX
Relative Strength Index (RSI) 49.89 38.65
Support Level $1.74 $3.99
Resistance Level $1.95 $6.39
Average True Range (ATR) 0.04 0.46
MACD -0.01 0.01
Stochastic Oscillator 8.33 32.81

Price Performance

Historical Comparison
HOUR
NSRX

About HOUR Hour Loop Inc.

Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: